| Animal models for COVID-19 C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ... Nature 586 (7830), 509-515, 2020 | 796 | 2020 |
| Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, L Pache, ... Nature 586 (7827), 113-119, 2020 | 727 | 2020 |
| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 488 | 2022 |
| SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling L Miorin, T Kehrer, MT Sanchez-Aparicio, K Zhang, P Cohen, RS Patel, ... Proceedings of the National Academy of Sciences 117 (45), 28344-28354, 2020 | 471 | 2020 |
| SARS-CoV-2 spike E484K mutation reduces antibody neutralisation S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, H Alshammary, ... The Lancet Microbe 2 (7), e283-e284, 2021 | 397 | 2021 |
| Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments M Schotsaert, M De Filette, W Fiers, X Saelens Expert review of vaccines 8 (4), 499-508, 2009 | 303 | 2009 |
| Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A KM White, R Rosales, S Yildiz, T Kehrer, L Miorin, E Moreno, S Jangra, ... Science 371 (6532), 926-931, 2021 | 296 | 2021 |
| M2e-based universal influenza A vaccine W Fiers, M De Filette, K El Bakkouri, B Schepens, K Roose, M Schotsaert, ... Vaccine 27 (45), 6280-6283, 2009 | 296 | 2009 |
| Virus-induced senescence is a driver and therapeutic target in COVID-19 S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ... Nature 599 (7884), 283-289, 2021 | 231 | 2021 |
| Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience C Bryce, Z Grimes, E Pujadas, S Ahuja, MB Beasley, R Albrecht, ... Modern Pathology 34 (8), 1456-1467, 2021 | 230 | 2021 |
| A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface S Bangaru, S Lang, M Schotsaert, HA Vanderven, X Zhu, N Kose, ... Cell 177 (5), 1136-1152. e18, 2019 | 202 | 2019 |
| Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection R Rathnasinghe, S Strohmeier, F Amanat, VL Gillespie, F Krammer, ... Emerging microbes & infections 9 (1), 2433-2445, 2020 | 173 | 2020 |
| Spatial-temporal lineage restrictions of embryonic p63+ progenitors establish distinct stem cell pools in adult airways Y Yang, P Riccio, M Schotsaert, M Mori, J Lu, DK Lee, A García-Sastre, ... Developmental cell 44 (6), 752-761. e4, 2018 | 166 | 2018 |
| Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 TA Tummino, VV Rezelj, B Fischer, A Fischer, MJ O’meara, B Monel, ... Science 373 (6554), 541-547, 2021 | 162 | 2021 |
| The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, F Krammer, V Simon, ... MedRxiv, 2021 | 136 | 2021 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 133 | 2022 |
| Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies M De Filette, W Martens, A Smet, M Schotsaert, A Birkett, ... Vaccine 26 (51), 6503-6507, 2008 | 126 | 2008 |
| The SARS-CoV-2 B. 1.1. 529 Omicron virus causes attenuated infection and disease in mice and hamsters M Diamond, P Halfmann, T Maemura, K Iwatsuki-Horimoto, S Iida, M Kiso, ... Research square, 2021 | 114 | 2021 |
| The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera R Rathnasinghe, S Jangra, A Cupic, C Martínez-Romero, LCF Mulder, ... MedRxiv, 2021 | 113 | 2021 |
| TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation JSY Ho, BWY Mok, L Campisi, T Jordan, S Yildiz, S Parameswaran, ... Cell 184 (10), 2618-2632. e17, 2021 | 83 | 2021 |
Bruno De GeestVerified email at ugent.Be
